Kuan-lin Huang

Kuan-lin Huang's research primarily focuses on understanding cancer-related molecular pathways, particularly in breast cancer, and exploring genomic insights into neurodegenerative diseases like Alzheimer's. Publicly indexed outputs suggest a strong emphasis on proteogenomics and genomic variant analysis, with a notable contribution to the development of tools for genomic interpretation. The portfolio, active between 2016 and 2020, includes several highly cited journal articles. These publications, co-authored with at least 15 distinct collaborators, have garnered significant attention, with a 2016 Nature paper on breast cancer proteogenomics receiving over 1700 citations and a 2017 Nature Neuroscience paper on Alzheimer's disease accumulating over 400 citations. This sustained output demonstrates an impactful contribution to both cancer and neuroscience research.